States Can Use the Coronavirus Response to Go After Insulin Price Gougers

April 9, 2020

The COVID-19 healthcare crisis is spreading beyond just those with the virus. As millions of Americans lose their jobs, they also stand to lose the employer-provided health insurance they rely on for life-saving drugs. Without insurance, the costs of those drugs can skyrocket. Insulin alone can cost $12,000 a year. So what can be done to keep insulin affordable during the crisis? One solution might come from a novel legal strategy that would test the limits of what constitutes illegal price gouging.

The articles on our Website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice.

Disclaimer
Back to Top